NK cells’ killing capacity is tightly regulated by the interaction with both its activating, such as NKG2D [159], and inhibitory molecules that have costimulating receptors (such as MHC class I chain-related polypeptide (MICA) A and B) and co-inhibitory receptors [160] expressed on the surface of cancer cells. This evidence concerns the gene MICA and cancer.